GARDASIL 9 is a vaccine that helps protect ... The tip cap and plunger stopper of the pre-filled syringe are not made with natural rubber latex. The vial stopper is not made with natural rubber ...

The prefilled syringes market has become a vital segment within the healthcare industry, combining efficiency and safety in medication delivery. As healthcare evolves, the growing demand for ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these ...

The new prefilled syringe removes the need to reconstitute separate vials prior to administration, offering a convenient option for physicians, pharmacists and other healthcare professionals who ...

compared with analysts estimates of $9.03 a share. Quarterly Gardasil sales of $1.55 billion missed Wall Street's estimates of around $1.8 billion, which has been pared back nearly 20% since the ...

The sales range reflects a decision to temporarily pause Gardasil/Gardasil 9 shipments into China beginning February 2025 through at least mid-year. The U.S. pharma giant expects adjusted EPS Of $ ...

The Global Smart Syringes Market size is expected to be worth around USD 23.9 billion by 2033 from USD 8.9 billion in 2023, growing at a CAGR of 10.4% The Drug Delivery Held A Significant Share Of ...

GSK plc announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix ... reported missing work for an average ...

The headwinds continue to play out despite Gardasil just last month nabbing an expanded approval in China to prevent certain HPV-related cancers and diseases in men ages 9 to 25, Merck pointed out ...

Bimzelx (bimekizumab-bkzx) is now commercially available by prescription in the United States in a 2 mL prefilled syringe and autoinjector, each containing 320 mg of Bimzelx. The single-injection ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...